Genetic Disorders Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Genetic Disorders Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genetic Disorders Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genetic Disorders Drug Overall Market Size
2.1 Global Genetic Disorders Drug Market Size: 2022 VS 2029
2.2 Global Genetic Disorders Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Genetic Disorders Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Genetic Disorders Drug Players in Global Market
3.2 Top Global Genetic Disorders Drug Companies Ranked by Revenue
3.3 Global Genetic Disorders Drug Revenue by Companies
3.4 Global Genetic Disorders Drug Sales by Companies
3.5 Global Genetic Disorders Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Genetic Disorders Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Genetic Disorders Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Genetic Disorders Drug Players in Global Market
3.8.1 List of Global Tier 1 Genetic Disorders Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Genetic Disorders Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Genetic Disorders Drug Market Size Markets, 2022 & 2029
4.1.2 Cystic Fibrosis (CF)
4.1.3 Duchenne Muscular Dystrophy (DMD)
4.1.4 Lysosomal Storage Disease (LSD)
4.1.5 Paroxysmal Nocturnal Hemoglobinuria (PNH)
4.2 By Type - Global Genetic Disorders Drug Revenue & Forecasts
4.2.1 By Type - Global Genetic Disorders Drug Revenue, 2018-2023
4.2.2 By Type - Global Genetic Disorders Drug Revenue, 2024-2029
4.2.3 By Type - Global Genetic Disorders Drug Revenue Market Share, 2018-2029
4.3 By Type - Global Genetic Disorders Drug Sales & Forecasts
4.3.1 By Type - Global Genetic Disorders Drug Sales, 2018-2023
4.3.2 By Type - Global Genetic Disorders Drug Sales, 2024-2029
4.3.3 By Type - Global Genetic Disorders Drug Sales Market Share, 2018-2029
4.4 By Type - Global Genetic Disorders Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genetic Disorders Drug Market Size, 2022 & 2029
5.1.2 Clinic
5.1.3 Hospital
5.2 By Application - Global Genetic Disorders Drug Revenue & Forecasts
5.2.1 By Application - Global Genetic Disorders Drug Revenue, 2018-2023
5.2.2 By Application - Global Genetic Disorders Drug Revenue, 2024-2029
5.2.3 By Application - Global Genetic Disorders Drug Revenue Market Share, 2018-2029
5.3 By Application - Global Genetic Disorders Drug Sales & Forecasts
5.3.1 By Application - Global Genetic Disorders Drug Sales, 2018-2023
5.3.2 By Application - Global Genetic Disorders Drug Sales, 2024-2029
5.3.3 By Application - Global Genetic Disorders Drug Sales Market Share, 2018-2029
5.4 By Application - Global Genetic Disorders Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Genetic Disorders Drug Market Size, 2022 & 2029
6.2 By Region - Global Genetic Disorders Drug Revenue & Forecasts
6.2.1 By Region - Global Genetic Disorders Drug Revenue, 2018-2023
6.2.2 By Region - Global Genetic Disorders Drug Revenue, 2024-2029
6.2.3 By Region - Global Genetic Disorders Drug Revenue Market Share, 2018-2029
6.3 By Region - Global Genetic Disorders Drug Sales & Forecasts
6.3.1 By Region - Global Genetic Disorders Drug Sales, 2018-2023
6.3.2 By Region - Global Genetic Disorders Drug Sales, 2024-2029
6.3.3 By Region - Global Genetic Disorders Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Genetic Disorders Drug Revenue, 2018-2029
6.4.2 By Country - North America Genetic Disorders Drug Sales, 2018-2029
6.4.3 US Genetic Disorders Drug Market Size, 2018-2029
6.4.4 Canada Genetic Disorders Drug Market Size, 2018-2029
6.4.5 Mexico Genetic Disorders Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Genetic Disorders Drug Revenue, 2018-2029
6.5.2 By Country - Europe Genetic Disorders Drug Sales, 2018-2029
6.5.3 Germany Genetic Disorders Drug Market Size, 2018-2029
6.5.4 France Genetic Disorders Drug Market Size, 2018-2029
6.5.5 U.K. Genetic Disorders Drug Market Size, 2018-2029
6.5.6 Italy Genetic Disorders Drug Market Size, 2018-2029
6.5.7 Russia Genetic Disorders Drug Market Size, 2018-2029
6.5.8 Nordic Countries Genetic Disorders Drug Market Size, 2018-2029
6.5.9 Benelux Genetic Disorders Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Genetic Disorders Drug Revenue, 2018-2029
6.6.2 By Region - Asia Genetic Disorders Drug Sales, 2018-2029
6.6.3 China Genetic Disorders Drug Market Size, 2018-2029
6.6.4 Japan Genetic Disorders Drug Market Size, 2018-2029
6.6.5 South Korea Genetic Disorders Drug Market Size, 2018-2029
6.6.6 Southeast Asia Genetic Disorders Drug Market Size, 2018-2029
6.6.7 India Genetic Disorders Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Genetic Disorders Drug Revenue, 2018-2029
6.7.2 By Country - South America Genetic Disorders Drug Sales, 2018-2029
6.7.3 Brazil Genetic Disorders Drug Market Size, 2018-2029
6.7.4 Argentina Genetic Disorders Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Genetic Disorders Drug Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Genetic Disorders Drug Sales, 2018-2029
6.8.3 Turkey Genetic Disorders Drug Market Size, 2018-2029
6.8.4 Israel Genetic Disorders Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Genetic Disorders Drug Market Size, 2018-2029
6.8.6 UAE Genetic Disorders Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Genetic Disorders Drug Major Product Offerings
7.1.4 Sanofi Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Vertex
7.2.1 Vertex Company Summary
7.2.2 Vertex Business Overview
7.2.3 Vertex Genetic Disorders Drug Major Product Offerings
7.2.4 Vertex Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.2.5 Vertex Key News & Latest Developments
7.3 Takeda
7.3.1 Takeda Company Summary
7.3.2 Takeda Business Overview
7.3.3 Takeda Genetic Disorders Drug Major Product Offerings
7.3.4 Takeda Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.3.5 Takeda Key News & Latest Developments
7.4 Amgen
7.4.1 Amgen Company Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Genetic Disorders Drug Major Product Offerings
7.4.4 Amgen Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.4.5 Amgen Key News & Latest Developments
7.5 GW Pharmaceuticals
7.5.1 GW Pharmaceuticals Company Summary
7.5.2 GW Pharmaceuticals Business Overview
7.5.3 GW Pharmaceuticals Genetic Disorders Drug Major Product Offerings
7.5.4 GW Pharmaceuticals Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.5.5 GW Pharmaceuticals Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Genetic Disorders Drug Major Product Offerings
7.6.4 Pfizer Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 BioMarin
7.7.1 BioMarin Company Summary
7.7.2 BioMarin Business Overview
7.7.3 BioMarin Genetic Disorders Drug Major Product Offerings
7.7.4 BioMarin Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.7.5 BioMarin Key News & Latest Developments
7.8 Sarepta
7.8.1 Sarepta Company Summary
7.8.2 Sarepta Business Overview
7.8.3 Sarepta Genetic Disorders Drug Major Product Offerings
7.8.4 Sarepta Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.8.5 Sarepta Key News & Latest Developments
8 Global Genetic Disorders Drug Production Capacity, Analysis
8.1 Global Genetic Disorders Drug Production Capacity, 2018-2029
8.2 Genetic Disorders Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Genetic Disorders Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Genetic Disorders Drug Supply Chain Analysis
10.1 Genetic Disorders Drug Industry Value Chain
10.2 Genetic Disorders Drug Upstream Market
10.3 Genetic Disorders Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Genetic Disorders Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Genetic Disorders Drug in Global Market
Table 2. Top Genetic Disorders Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Genetic Disorders Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Genetic Disorders Drug Revenue Share by Companies, 2018-2023
Table 5. Global Genetic Disorders Drug Sales by Companies, (K Doses), 2018-2023
Table 6. Global Genetic Disorders Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Genetic Disorders Drug Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Genetic Disorders Drug Product Type
Table 9. List of Global Tier 1 Genetic Disorders Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genetic Disorders Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Genetic Disorders Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Genetic Disorders Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Genetic Disorders Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Genetic Disorders Drug Sales (K Doses), 2018-2023
Table 15. By Type - Global Genetic Disorders Drug Sales (K Doses), 2024-2029
Table 16. By Application ? Global Genetic Disorders Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Genetic Disorders Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Genetic Disorders Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Genetic Disorders Drug Sales (K Doses), 2018-2023
Table 20. By Application - Global Genetic Disorders Drug Sales (K Doses), 2024-2029
Table 21. By Region ? Global Genetic Disorders Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Genetic Disorders Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Genetic Disorders Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Genetic Disorders Drug Sales (K Doses), 2018-2023
Table 25. By Region - Global Genetic Disorders Drug Sales (K Doses), 2024-2029
Table 26. By Country - North America Genetic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Genetic Disorders Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Genetic Disorders Drug Sales, (K Doses), 2018-2023
Table 29. By Country - North America Genetic Disorders Drug Sales, (K Doses), 2024-2029
Table 30. By Country - Europe Genetic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Genetic Disorders Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Genetic Disorders Drug Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Genetic Disorders Drug Sales, (K Doses), 2024-2029
Table 34. By Region - Asia Genetic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Genetic Disorders Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Genetic Disorders Drug Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Genetic Disorders Drug Sales, (K Doses), 2024-2029
Table 38. By Country - South America Genetic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Genetic Disorders Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Genetic Disorders Drug Sales, (K Doses), 2018-2023
Table 41. By Country - South America Genetic Disorders Drug Sales, (K Doses), 2024-2029
Table 42. By Country - Middle East & Africa Genetic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Genetic Disorders Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Genetic Disorders Drug Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Genetic Disorders Drug Sales, (K Doses), 2024-2029
Table 46. Sanofi Company Summary
Table 47. Sanofi Genetic Disorders Drug Product Offerings
Table 48. Sanofi Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. Vertex Company Summary
Table 51. Vertex Genetic Disorders Drug Product Offerings
Table 52. Vertex Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. Vertex Key News & Latest Developments
Table 54. Takeda Company Summary
Table 55. Takeda Genetic Disorders Drug Product Offerings
Table 56. Takeda Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Takeda Key News & Latest Developments
Table 58. Amgen Company Summary
Table 59. Amgen Genetic Disorders Drug Product Offerings
Table 60. Amgen Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. Amgen Key News & Latest Developments
Table 62. GW Pharmaceuticals Company Summary
Table 63. GW Pharmaceuticals Genetic Disorders Drug Product Offerings
Table 64. GW Pharmaceuticals Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. GW Pharmaceuticals Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Genetic Disorders Drug Product Offerings
Table 68. Pfizer Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. BioMarin Company Summary
Table 71. BioMarin Genetic Disorders Drug Product Offerings
Table 72. BioMarin Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. BioMarin Key News & Latest Developments
Table 74. Sarepta Company Summary
Table 75. Sarepta Genetic Disorders Drug Product Offerings
Table 76. Sarepta Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. Sarepta Key News & Latest Developments
Table 78. Genetic Disorders Drug Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 79. Global Genetic Disorders Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Genetic Disorders Drug Production by Region, 2018-2023 (K Doses)
Table 81. Global Genetic Disorders Drug Production by Region, 2024-2029 (K Doses)
Table 82. Genetic Disorders Drug Market Opportunities & Trends in Global Market
Table 83. Genetic Disorders Drug Market Drivers in Global Market
Table 84. Genetic Disorders Drug Market Restraints in Global Market
Table 85. Genetic Disorders Drug Raw Materials
Table 86. Genetic Disorders Drug Raw Materials Suppliers in Global Market
Table 87. Typical Genetic Disorders Drug Downstream
Table 88. Genetic Disorders Drug Downstream Clients in Global Market
Table 89. Genetic Disorders Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Genetic Disorders Drug Segment by Type in 2022
Figure 2. Genetic Disorders Drug Segment by Application in 2022
Figure 3. Global Genetic Disorders Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Genetic Disorders Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Genetic Disorders Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Genetic Disorders Drug Sales in Global Market: 2018-2029 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Genetic Disorders Drug Revenue in 2022
Figure 9. By Type - Global Genetic Disorders Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Genetic Disorders Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Genetic Disorders Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Genetic Disorders Drug Price (USD/Dose), 2018-2029
Figure 13. By Application - Global Genetic Disorders Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Genetic Disorders Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Genetic Disorders Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Genetic Disorders Drug Price (USD/Dose), 2018-2029
Figure 17. By Region - Global Genetic Disorders Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Genetic Disorders Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Genetic Disorders Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Genetic Disorders Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Genetic Disorders Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Genetic Disorders Drug Sales Market Share, 2018-2029
Figure 23. US Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Genetic Disorders Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Genetic Disorders Drug Sales Market Share, 2018-2029
Figure 28. Germany Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Genetic Disorders Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Genetic Disorders Drug Sales Market Share, 2018-2029
Figure 37. China Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Genetic Disorders Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Genetic Disorders Drug Sales Market Share, 2018-2029
Figure 44. Brazil Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Genetic Disorders Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Genetic Disorders Drug Sales Market Share, 2018-2029
Figure 48. Turkey Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Genetic Disorders Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Genetic Disorders Drug Production Capacity (K Doses), 2018-2029
Figure 53. The Percentage of Production Genetic Disorders Drug by Region, 2022 VS 2029
Figure 54. Genetic Disorders Drug Industry Value Chain
Figure 55. Marketing Channels
Industry Market Size
